Plant Comparison
Andrographis vs Witch Hazel
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Andrographis and Witch Hazel: they share 5 indicated uses (arthritis / joint pain, cancer (anticancer research), inflammation (general), …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Andrographis | Witch Hazel | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 5/10 | Comparable evidence |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 5/10 | 5/10 | Comparable evidence |
| Skin irritation | 5/10 | 5/10 | Comparable evidence |
| Wounds | 5/10 | 1/10 | Stronger for Andrographis |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The principal astringent and anti-inflammatory constituents.
Antioxidant and anti-inflammatory constituents of the bark and leaf.
Pharmacological Actions
Andrographolide, the principal diterpene lactone of Andrographis paniculata, suppresses proliferation and induces apoptosis across breast, lung, colon, cervical, hepatic and haematological cancers via NF-kappaB and PI3K/Akt inhibition (preclinical).
Anti-inflammatory and antioxidant (supports irritated/atopic skin); Relief of haemorrhoid symptoms (astringent and anti-inflammatory)
Astringent for skin irritation and minor inflammation of the skin and oral mucosa (tannins), applied topically; Relief of haemorrhoid symptoms (astringent and anti-inflammatory)
Traditional & Indicated Uses
inferred from anti-inflammatory action
Andrographolide (from Andrographis paniculata) acts as a chemopreventive and antitumour agent against breast, lung, colorectal, cervical, prostate and hepatocellular cancers and leukaemia, inducing apoptosis and inhibiting NF-kappaB and PI3K/AKT signalling (preclinical).
Symptomatic relief of the common cold and acute upper respiratory tract infection (reduces symptom severity and duration)
Immunostimulant / immune support
Symptomatic relief of the common cold and acute upper respiratory tract infection (reduces symptom severity and duration)
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Vulnerary for minor wounds, bruises and insect bites
inferred from anticancer action
Relief of haemorrhoid symptoms (astringent and anti-inflammatory)
Astringent for skin irritation and minor inflammation of the skin and oral mucosa (tannins), applied topically
Astringent for skin irritation and minor inflammation of the skin and oral mucosa (tannins), applied topically
Astringent for skin irritation and minor inflammation of the skin and oral mucosa (tannins), applied topically
Safety, Cautions & Contraindications
Avoid in pregnancy and when trying to conceive: high doses have shown reproductive toxicity in animals and the herb has a traditional reputation as an abortifacient.
High doses have caused nephrotoxicity and reproductive toxicity in studies; use standardized products at recommended doses and avoid prolonged high-dose use.
For topical use. Do not apply to deep wounds, serious burns or severe rectal bleeding - these need medical care.
External Ids
Botanical Description
Erect, branching annual herb with a slender, quadrangular (square-sectioned), dark green stem. The leaves are opposite, lance-shaped and glabrous, with a short stalk. Small, two-lipped, white flowers with purple-pink markings are borne in loose, spreading axillary and terminal racemes. The whole plant, and especially the leaves, is intensely and characteristically bitter.[11]
Large, multi-stemmed deciduous shrub or small tree with broad, oval, wavy-toothed leaves, asymmetrical at the base. Unusually, it flowers in late autumn to winter after the leaves have fallen, bearing clusters of small, spidery, bright yellow flowers with narrow, crinkled, ribbon-like petals. The woody seed capsule matures the following autumn and explosively ejects its seeds ('snapping hazelnut').[14]
Habitat
Native to India and Sri Lanka and widely distributed through South and Southeast Asia, growing wild in plains, hillsides, roadsides and cultivated fields; also grown commercially as a medicinal crop.[11]
Native to woodland understorey and forest margins of eastern North America; widely cultivated as an ornamental and medicinal shrub.[14]
Harvesting
The aerial parts (leaves and tender stems) are cut just before or at the onset of flowering, when andrographolide content is typically highest, and dried in shade to preserve the bitter diterpenoid lactones.[11]
Bark is stripped from branches (not the main trunk, to avoid harming the plant) and leaves are picked in summer; both are dried for use, or steam-distilled together with twigs to produce distilled witch-hazel water, the most common commercial form.[14]
Traditional Uses
Andrographis, the 'king of bitters', is a cornerstone bitter tonic of Ayurvedic and traditional Chinese medicine (Chuan xin lian), used for fevers, colds, sore throat, infections and liver complaints. This traditional reputation for treating the common cold and upper respiratory infections is now supported by clinical trials of standardised extracts.[10, 12]
Witch hazel has a long Native American and, after adoption by European settlers, worldwide reputation as a topical astringent and anti-inflammatory remedy for skin irritation, minor wounds, bruises, insect bites and haemorrhoids, and as a soothing wash for irritated skin and mucous membranes.[14]
Preparations
Dried aerial parts infused or lightly decocted in hot water as a very bitter traditional fever and cold remedy.
Dosage
Clinical trials for upper respiratory infection commonly use extracts standardised to around 60-120 mg andrographolide daily, in divided doses, for up to 5-7 days. Educational reference only, not a prescription.
The WHO monograph on Herba Andrographidis gives, by indication - for the common cold, 1.5-3.0 g of the powdered crude drug three times daily, after meals and at bedtime; for pyrexia, a decoction from 3 g of the crude drug twice daily; for diarrhoea, a decoction from 3-9 g as a single dose as needed, or two 500 mg tablets four times daily. Note that the EMA HMPC assessed this herb and issued a public statement rather than a monograph, so there is no EU posology. Educational reference only, not a prescription.
The EU herbal monograph on Hamamelis virginiana L., cortex gives, for cutaneous use, tincture at a strength corresponding to 5-10% in semi-solid preparations several times daily, or a dry extract (5-7.7:1, ethanol 30% m/m) at a strength corresponding to 1.3% as an ointment several times daily; for anorectal use, a decoction of 5-10 g per 250 mL up to 3 times daily as impregnated dressings. For topical use only. Educational reference only, not a prescription.
References
Lookalikes Review
References & Sources
- Okonogi, R. and others (2023) 'Efficacy of Andrographis paniculata spray in acute pharyngitis: A randomized controlled trial', Drug Discoveries & Therapeutics, 17(5), pp. 315-321. doi:10.5582/ddt.2023.01053 Randomized trial
https://doi.org/10.5582/ddt.2023.01053 - Hossain, S., Urbi, Z., Karuniawati, H., Mohiuddin, R.B. and others (2018) 'Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide', Critical Reviews in Food Science and Nutrition, 61(10), pp. 1635-1652. doi:10.1080/10408398.2018.1501657 Meta-analysis / review
https://doi.org/10.1080/10408398.2018.1501657 - Worakunphanich, W. and others (2021) 'Andrographis paniculata Formulations: Impact on Diterpene Lactone Oral Bioavailability', European Journal of Drug Metabolism and Pharmacokinetics, 46(5), pp. 565-581. doi:10.1007/s13318-021-00736-7 Meta-analysis / review
https://doi.org/10.1007/s13318-021-00736-7 - Worakunphanich, W., Thavorncharoensap, M., Youngkong, S., Thakkinstian, A. and Chaikledkaew, U (2021) 'Safety of Andrographis paniculata: A systematic review and meta-analysis', Pharmacoepidemiology and Drug Safety, 30(6), pp. 727-739. doi:10.1002/pds.5190 Meta-analysis / review
https://doi.org/10.1002/pds.5190 - Kumar, S., Singh, B. and Bajpai, V (2021) 'Andrographis paniculata (Burm.f.) Nees and its major constituent andrographolide as potential antiviral agents', Journal of Ethnopharmacology, 274, pp. 113954. doi:10.1016/j.jep.2021.113954 Meta-analysis / review
https://doi.org/10.1016/j.jep.2021.113954 - Barbosa, F.L. and others (2021) 'Andrographis paniculata (Burm. f.) Wall. ex Nees: An Updated Review of Phytochemistry, Antimicrobial Pharmacology, and Clinical Safety and Efficacy', Life, 11(4), pp. 348. doi:10.3390/life11040348 Meta-analysis / review
https://doi.org/10.3390/life11040348 - Singh, P. and others (2022) 'Andrographis paniculata mitigates first-line anti-tubercular drugs-induced nephrotoxicity in Wistar rats', Biomarkers, 27(4), pp. 385-394. doi:10.1080/1354750X.2022.2043444 Preclinical
https://doi.org/10.1080/1354750X.2022.2043444 - Coon, J.T. and Ernst, E (2004) 'Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials', Journal of Clinical Pharmacy and Therapeutics, 29(1), pp. 37-45. doi:10.1046/j.1365-2710.2003.00534.x Meta-analysis / review
https://doi.org/10.1046/j.1365-2710.2003.00534.x - Rondee, N. and others (2023) 'The Effects of Andrographis paniculata (Burm.F.) Wall. Ex Nees and Andrographolide on Neuroinflammation in the Treatment of Neurodegenerative Diseases', Nutrients, 15(15), pp. 3428. doi:10.3390/nu15153428 Meta-analysis / review
https://doi.org/10.3390/nu15153428 - Zeng, B., Wei, A., Zhou, Q., Yuan, M., Lei, K., Liu, Y., Song, J., Guo, L. and Ye, Q (2021) 'Andrographolide: A review of its pharmacology, pharmacokinetics, toxicity and clinical trials and pharmaceutical researches', Phytotherapy Research. doi:10.1002/ptr.7324 Randomized trial
https://doi.org/10.1002/ptr.7324 - Gonde, D.P., Bhole, B.K. and Kakad, K.S (2023) 'Andrographolide, diterpenoid constituent of Andrographis paniculata: Review on botany, phytochemistry, molecular docking analysis, and pharmacology', Annales Pharmaceutiques Francaises. doi:10.1016/j.pharma.2023.10.001 Preclinical
https://doi.org/10.1016/j.pharma.2023.10.001 - Hu, X.Y., Wu, R.H., Logue, M., Blondel, C., Lai, L.Y.W., Stuart, B., Flower, A., Fei, Y.T., Moore, M., Shepherd, J., Liu, J.P. and Lewith, G (2017) 'Andrographis paniculata (Chuan Xin Lian) for symptomatic relief of acute respiratory tract infections in adults and children: A systematic review and meta-analysis', PLoS ONE. doi:10.1371/journal.pone.0181780 Meta-analysis / review
https://doi.org/10.1371/journal.pone.0181780 - World Health Organization (2002) 'Herba Andrographidis'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 - Tundis, R. and Patra, J.K. and Bonesi, M. and Das, S. and Nath, R. and Das Talukdar, A. and Das, G. and Loizzo, M.R (2023) 'Anti-Cancer Agent: The Labdane Diterpenoid-Andrographolide', Plants, 12(10), pp. 1969. doi:10.3390/plants12101969 Preclinical
https://doi.org/10.3390/plants12101969 - Mishra, S.K. and Tripathi, S. and Shukla, A. and Oh, S.H. and Kim, H.M (2015) 'Andrographolide and analogues in cancer prevention', Frontiers in Bioscience (Elite Edition), 7(2), pp. 255-266. doi:10.2741/E732 Preclinical
https://doi.org/10.2741/E732 - Paul, S. and Roy, D. and Pati, S. and Sa, G (2021) 'The Adroitness of Andrographolide as a Natural Weapon Against Colorectal Cancer', Frontiers in Pharmacology, 12, pp. 731492. doi:10.3389/fphar.2021.731492 Preclinical
https://doi.org/10.3389/fphar.2021.731492 - Memorial Sloan Kettering Cancer Center (n.d.) 'Andrographis (About Herbs)'. Available at: https://www.mskcc.org/cancer-care/integrative-medicine/herbs/andrographis Traditional / reference
https://www.mskcc.org/cancer-care/integrative-medicine/herbs/andrographis
- Skowrońska, W., Pawłowska, K.A., Obrębski, M., Piwowarski, J.P. et al (2025) 'Chemical composition, skin microbiota metabolism, antimicrobial potential and anti-inflammatory properties of witch hazel bark (Hamamelis virginiana L.)', Journal of Ethnopharmacology, 353(Pt B), pp. 120433. doi:10.1016/j.jep.2025.120433 Preclinical
https://doi.org/10.1016/j.jep.2025.120433 - Piazza, S., Martinelli, G., Vrhovsek, U., Masuero, D. et al (2022) 'Anti-Inflammatory and Anti-Acne Effects of Hamamelis virginiana Bark in Human Keratinocytes', Antioxidants (Basel), 11(6), pp. 1119. doi:10.3390/antiox11061119 Preclinical
https://doi.org/10.3390/antiox11061119 - Janarthanam, V.A., Rajan, P.S.S., Panda, S.P., Panigrahy, U.P. et al (2025) 'Hamamelitannin from Hamamelis virginiana Attenuates Ethanol-Induced Oxidative and Inflammatory Responses in Danio rerio Larvae', Molecular Biotechnology, 68(5), pp. 2369-2385. doi:10.1007/s12033-025-01502-9 Preclinical
https://doi.org/10.1007/s12033-025-01502-9 - Piazza, S., Martinelli, G., Magnavacca, A., Fumagalli, M., Pozzoli, C., Terno, M., Canilli, L., Angarano, M., Maranta, N., Dell'Agli, M. and Sangiovanni, E (2022) 'Unveiling the Ability of Witch Hazel (Hamamelis virginiana L.) Bark Extract to Impair Keratinocyte Inflammatory Cascade Typical of Atopic Eczema', International Journal of Molecular Sciences, 23(16), pp. 9279. doi:10.3390/ijms23169279 Preclinical
https://doi.org/10.3390/ijms23169279 - Amendola, I., Viegas, D.J., Freitas, E.T., Oliveira, J.R., Santos, J.G., Oliveira, F.E., Lagareiro Netto, A.A., Marcucci, M.C., Oliveira, L.D. and Back-Brito, G.N (2024) 'Hamamelis virginiana L. extract presents antimicrobial and antibiofilm effects, absence of cytotoxicity, anti-inflammatory action, and potential to fight infections through the nitric oxide production by macrophages', Anais da Academia Brasileira de Ciencias, 96(1), pp. e20200031. doi:10.1590/0001-3765202320200031 Preclinical
https://doi.org/10.1590/0001-3765202320200031 - Habtemariam, S (2002) 'Hamamelitannin from Hamamelis virginiana inhibits the tumour necrosis factor-alpha (TNF)-induced endothelial cell death in vitro', Toxicon, 40(1), pp. 83-88. doi:10.1016/s0041-0101(01)00195-7 Preclinical
https://doi.org/10.1016/s0041-0101(01)00195-7 - Natella, F., Guantario, B., Ambra, R., Ranaldi, G., Intorre, F., Burki, C. and Canali, R (2021) 'Human Metabolites of Hamamelis virginiana (Extract) Modulate Fibroblast Extracellular Matrix Components in Response to UV-A Irradiation', Frontiers in Pharmacology, 12, pp. 747638. doi:10.3389/fphar.2021.747638 Randomized trial
https://doi.org/10.3389/fphar.2021.747638 - Dauer, A., Rimpler, H. and Hensel, A (2003) 'Polymeric proanthocyanidins from the bark of Hamamelis virginiana', Planta Medica, 69(1), pp. 89-91. doi:10.1055/s-2003-37022 Preclinical
https://doi.org/10.1055/s-2003-37022 - Vennat, B., Pourrat, H., Pouget, M.P., Gross, D. and Pourrat, A (1988) 'Tannins from Hamamelis virginiana: identification of proanthocyanidins and hamamelitannin quantification in leaf, bark, and stem extracts', Planta Medica, 54(5), pp. 454-457. doi:10.1055/s-2006-962499 Preclinical
https://doi.org/10.1055/s-2006-962499 - Duckstein, S.M., Lorenz, P. and Stintzing, F.C (2012) 'Conversion of phenolic constituents in aqueous Hamamelis virginiana leaf extracts during fermentation', Phytochemical Analysis, 23(6), pp. 588-597. doi:10.1002/pca.2359 Preclinical
https://doi.org/10.1002/pca.2359 - Sanchez-Tena, S., Fernandez-Cachon, M.L., Carreras, A., Mateos-Martin, M.L., Costoya, N., Moyer, M.P., Nunez, M.J., Torres, J.L. and Cascante, M (2012) 'Hamamelitannin from witch hazel (Hamamelis virginiana) displays specific cytotoxic activity against colon cancer cells', Journal of Natural Products, 75(1), pp. 26-33. doi:10.1021/np200426k Preclinical
https://doi.org/10.1021/np200426k - Theisen, L.L., Erdelmeier, C.A.J., Spoden, G.A., Boukhallouk, F., Sausy, A., Florin, L. and Muller, C.P (2014) 'Tannins from Hamamelis virginiana bark extract: characterization and improvement of the antiviral efficacy against influenza A virus and human papillomavirus', PLoS One, 9(1), pp. e88062. doi:10.1371/journal.pone.0088062 Preclinical
https://doi.org/10.1371/journal.pone.0088062 - Cheesman, M.J., Alcorn, S.R., White, A. and Cock, I.E (2023) 'Hamamelis virginiana L. Leaf Extracts Inhibit the Growth of Antibiotic-Resistant Gram-Positive and Gram-Negative Bacteria', Antibiotics, 12(7), pp. 1195. doi:10.3390/antibiotics12071195 Preclinical
https://doi.org/10.3390/antibiotics12071195 - European Medicines Agency (HMPC) (n.d.) 'European Union herbal monograph on Hamamelis virginiana L., cortex/folium/aqua (Hamamelidis cortex)'. Available at: https://www.ema.europa.eu/en/medicines/herbal/hamamelidis-cortex Traditional / reference
https://www.ema.europa.eu/en/medicines/herbal/hamamelidis-cortex - (2025) 'Hamamelis virginiana L. in Skin Care: A Review of Its Pharmacological Properties and Cosmetological Applications', Molecules. doi:10.3390/molecules30132744 Randomized trial
https://doi.org/10.3390/molecules30132744 - Herbal Reality (n.d.) 'Witch Hazel (Hamamelis virginiana): Benefits, Safety, Uses'. Available at: https://www.herbalreality.com/herb/witch-hazel/ Traditional / reference
https://www.herbalreality.com/herb/witch-hazel/
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.